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Introduction
Sensory information in the area innervated by the trigeminal nerve is relayed from trigeminal afferents to second order neurons in the trigeminal spinal nucleus (SpV) in the brain stem and the upper cervical spinal cord (Iwata et al., 2017) . The SpV is an important relay station in the transmission of orofacial sensory information and this nucleus is functionally subdivided into three nuclei (from rostral to caudal): oralis, interpolarlis and caudalis (Sessle, 2000) . It is well known that the SpV caudalis (SpVc) is an important relay station for trigeminal nociceptive inputs from inflammation and tissue injury (Sessle, 2000; Takeda et al., 2012; Iwata et al., 2017) . SpVc nociceptive neurons are classified as nociceptive specific or wide-dynamic range (WDR) based on their sensitivity to mechanical stimulation applied to the orofacial area, such as the facial skin. Nociceptivespecific neurons respond only to noxious stimulation of the receptive field, suggesting these neurons encode stimulus localization (Iwata et al., 2017) . However, WDR neurons respond to both noxious and non-noxious stimulation. Graded noxious stimuli applied to the receptive field produce an increased firing frequency of SpVc WDR neurons in proportion to the stimulus intensity, suggesting that WDR neurons encode stimulus intensity. Since chronic pathological conditions, such as tissue inflammation, can change the properties of somatic sensory pathways, leading to hyperalgesia and allodynia (Scholz and Woolf, 2002) , previous studies have suggested that WDR neurons in the SpVc region have an important role in the mechanism underlying hyperalgesia/allodynia and/or referred pain associated with orofacial pain (Takeda et al., 2000; Nishikawa et al., 2004; Takeda et al., 2005 Takeda et al., , 2012 .
The endogenous compound, α-lipoic acid (1,2-dithiolane-3-pentanoic acid: LA), is a A C C E P T E D M A N U S C R I P T powerful scavenger of free radicals and a metal chelator (Packer et al., 1995) . Recent studies have shown that LA is an effective analgesia agent in various animals (Cameron et al., 2001; Patton et al., 2007; Memeo and Loiero, 2008) . For example, LA blocks oxidative stress at the spinal cord and controls the activity of nociceptive spinal neurons during diabetes, via potassium-chloride transporter 2 (KCC2), suggesting LA alleviates diabetes-induced mechanical hyperalgesia (Cameron et al., 2001) . A recent study also demonstrated that LA mediates the selective inhibition of T-type Ca 2+ channels in nociceptive dorsal root ganglion (DRG) neurons (Lee et al., 2009) . Since recent molecular and genetic studies have established that T-type Ca 2+ channels in the DRG function as signal amplifiers of both acute and chronic pain (Bourinet et al., 2005; Choi et al., 2007) , it can be assumed that the T-type Ca 2+ channel plays an important role in the analgesic effect (Lee et al., 2009) .
Recently it has been reported that a health food compound supplement containing LA (Koshirax; FANCL Corporation, Japan) provided some relief for patients with lower back pain, and therefore could be useful in managing lower back pain, and as a safe alternative or complement to non-steroidal anti-inflammatory therapy (Tarumizu et al., 2015) . This compound supplement, Koshirax, also contains the amino acid, theanine (γ-glutamylethylamide). Theanine is an amino acid derivate of glutamic acid found almost exclusively in certain teas. Theanine extracts from green tea have been suggested to prevent and cure cancer via intrinsic biological activity (Weiner et al., 2009) . In a previous study, we showed that acute intravenous administration of theanine suppresses nociceptive SpVc WDR neuronal activity in a concentration-dependent manner and this effect was reversible (Takehana et al., 2017) .
Taken together, these findings strongly suggest that systemic LA administration may suppress sensory transmission, including nociception, via blocking T-type Ca 2+ channels.
On the basis of these observations, we hypothesized that intravenous LA administration would attenuate the noxious stimulation-induced excitability of SpVc WDR neuronal activity through peripheral and central mechanisms, as is the case for analgesic drugs.
However, the acute effects of LA on trigeminal neuronal activity in vivo in response to nociceptive and non-nociceptive mechanical stimulation remain to be determined. Thus,
the aim of the present study was to investigate whether acute intravenous administration of LA to rats could attenuate the excitability of nociceptive SpVc WDR neuronal activity in vivo in response to mechanical stimulation.
Materials and methods
The experiments described herein were approved by the Animal Use and Care
Committee of Azabu University and were performed in accordance with the guidelines of the International Association for the Study of Pain (Zimmermann, 1983) . Every effort was made to minimize the number of animals used and their suffering.
Extracellular single unit recording of WDR neuronal activity in the SpVc
Electrophysiological recordings were made in 17 adult male Wistar rats weighing 180-230g. Rats were anesthetized with pentobarbital sodium (48 mg/kg, i.p.) and anesthesia was maintained with additional doses of pentobarbital sodium at 2-3 mg/kg/h through a cannula into the jugular vein, as required. The level of anesthesia was confirmed by the absence of the corneal reflex and a lack of response to paw pinching. Rectal temperature was maintained at 37.0 ± 0.5C with a homeothermic blanket during recording. Rats were placed in a stereotaxic apparatus, and the activity of a single neuron from the SpVc region was recorded extracellularly. Single neuron activity was recorded using a glass micropipette filled with 2% pontamine sky blue and 0.5 M sodium acetate, according to the stereotaxic coordinates of Paxinos and Watson (1986) . Neuronal activity was amplified (DAM 80; World Precision Instruments, Sarasota, FL, USA), filtered (0.3-10 kHz), monitored with an oscilloscope (SS-7672; Iwatsu, Tokyo, Japan), and recorded on a polygraph (NEC-Sanei 8M14) for subsequent off-line analysis using PowerLab and Chart 5 software (ADInstruments, Oxford, UK).
Experimental protocols
Extracellular recordings of SpVc WDR unit activity were made as follows.
Mechanical stimulation was used as a stimulus to identify the receptive field quickly and to avoid sensitization of peripheral receptors. Single units that responded to stimulation of the left side of the orofacial facial skin (whisker pad) with a brush and a set of von Frey hairs (Semmes-Weinstein Monofilaments; North Coast Medical, Gilroy, CA, USA) were identified. Noxious pinch stimulation, which evoked a pain sensation when applied to a
human subject, was applied to the orofacial area using forceps. After identification of the left side of WDR SpVc neurons responding to stimulation of the whisker pad, we determined whether there was spontaneous discharge. The threshold for mechanical stimulation was determined using non-noxious and noxious mechanical stimulation (5 s) with von Frey hairs ( 6, 10, 15, 60 g ) at the interval of 5 s. The mechanical receptive field of neurons was mapped by probing the facial skin with von Frey hairs, and then outlined on a life-sized drawing of a rat on tracing paper. The WDR neuronal discharges induced by mechanical stimulation were quantified by subtracting background activity from evoked activity. Spontaneous discharge frequencies were determined over a period of 2-5 min. If no discharge was recorded, the cell was deemed a silent neuron. The mean firing rate of SpVc WDR neurons evoked by mechanical stimulation was compared before and after drug administration. Since previous studies have demonstrated that WDR neurons in the SpVc region have an important role in the mechanism underlying hyperalgesia and referred pain associated with orofacial pain (Takeda et al., 2000; Nishikawa et al., 2004; Takeda et al., 2005 Takeda et al., , 2012 , the focus of the present study was on the effects of LA on SpVc WDR neuronal activity, and so we did not examine nociceptive-specific neurons (Ness and Randich, 2000) . Post-stimulus histograms (bin = 100 ms) were generated in response to each stimulus. The effects of LA (volume:200μL,1, 10, and 100 mM), injected through a cannula into the jugular vein, were evaluated 5, 10, 20, and 30 min after administration because peak effect and recovery were thought to occur during this period.
LA was dissolved in dimethyl sulfoxide (DMSO). The stock solution was stored at -20℃ in small aliquots until use and then diluted in saline. The mean spontaneous and mechanical stimulation-induced discharges rates, as well as the mechanical threshold before and after intravenous administration of LA, were evaluated in the present study.
We also compared the mean magnitude of inhibition by LA of SpVc WDR neuronal discharge frequency between non-noxious (mean value for 6 and 10g) and noxious (mean value for 15, 60g and pinch) stimuli were evaluated in this study
Identification of recording sites
Recording sites of SpVc WDR neuronal activity were identified as described Takeda et al., 2000 Takeda et al., , 2012 . Briefly, at the end of the recording sessions, rats were deeply anesthetized and anodal DC currents (30 μA, 5 min) were passed through a recording micropipette. The rats were then perfused transcardially with saline and 10%
formalin. Frozen coronal sections (30 μm) were cut and stained with hematoxylin-eosin.
Recording sites were identified from the blue spots, and the path of the electrode tracks was constructed in combination with micromanipulator readings.
Data analysis
Values are expressed as the mean ± standard error of the mean. Statistical analyses were performed using one-way repeated-measures analysis of variance followed by TukeyKramer or Dunnett's post hoc tests for electrophysiological data. A p-value < 0.05 was considered significant.
Results

General properties of SpVc WDR neurons innervating the facial skin
Extracellular single unit activity was recorded from 17 neurons in the SpVc. The
SpVc neurons responding to non-noxious and noxious mechanical stimulation exhibited a somatic receptive field in the orofacial area (mainly whisker pad; Fig.1A ), as described previously (Takeda et al., 2000 (Takeda et al., , 2012 Takehana et al., 2016) . In addition, all these neurons responded to mechanical stimulation of the receptive field innervated by ophthalmic and maxillary branches. One of the 17 units exhibited spontaneous discharges.
As shown in 
Effects of LA on excitability of SpVc WDR neurons in response to non-noxious stimuli
A typical example of the effect of LA (100 mM, i.v.) on the excitability of SpVc WDR neurons in response to non-noxious mechanical stimulation is shown in Fig. 2 . Five min after injection of LA, non-noxious (6 and10 g) mechanical stimulation-evoked SpVc WDR neuronal activity was inhibited, but this inhibition disappeared, with activity returning to control levels, within approximately 10 min. There were no obvious changes in the size of the receptive field (19.3 ± 0.1 mm 2 vs. 19.1 ± 0.2 mm 2 , n.s.) or in the mechanical threshold after LA administration. SpVc WDR neuronal activity evoked by non-noxious mechanical stimulation is summarized in Fig. 3 . After intravenous LA injection, there was a significant decrease in the mean firing rate of non-noxious mechanical stimulation-evoked SpVc WDR neuronal activity, which eventually returned to control levels. Mean firing rates before and after LA were 19.9 ± 3.2 and 10.0 ± 1.8 Hz, respectively, in response to the 6-g stimulus and 27.5 ± 6.5 and 15.3 ± 2.1 Hz, respectively,
in response to the 10-g stimulus (6 g, F = 10.5; 10 g, F = 4.1; n = 7, p < 0.05 for both).
The suppression of SpVc WDR neuronal firing in response to non-noxious mechanical stimulation was significantly greater following the intravenous injection of 100 mM LA compared to 1 mM LA (42.7% ± 9.2% vs. 7.1% ± 5.5%, respectively, for the 6-g stimulus, F = 4.3; and 47.1% ± 6.5% vs. 18.3% ± 8.3%, respectively, for the 10-g stimulus, F = 7.0; n = 6, p < 0.05 for both; Fig. 4 ). As indicated in Fig. 3 , the mean firing rates of SpVc WDR neurons evoked by noxious mechanical and pinch stimulation decreased significantly after injection of LA compared with control (before drug injection): 31.7 ± 7.4 vs. 17.8 ± 3.4 Hz, respectively, for the 15-g stimulus; 42.0 ± 8.9 vs. 22.3 ± 3.6 Hz, respectively, for the 60-g stimulus; and 50.9 ± 9.1 vs. 28.1 ± 3.9 Hz, respectively, for the pinch stimulus (15 g, F = 5.8; 60 g, F = 6.1; pinch, F = 5.3; n = 6, p < 0.05 for all). The suppression of SpVc WDR neuronal firing in response to noxious mechanical and pinch stimulation was significantly greater following intravenous injection of 100 mM LA compared to 1 mM LA (46.6% ± 7.4% vs. 25.7% ± 4.4%, respectively, for the 15-g stimulus, F = 4.1; 46.6% ± 5.7% vs. 25.9% ± 4.4%, respectively, for the 60-g stimulus, F = 33.6; and 46.9% ± 5.7% vs. 24.5% ± 8.8%, respectively, for the pinch stimulus, F = 5.7; n = 7, p < 0.05 for all; Fig. 4) . No significant changes were observed in the mean receptive field size after LA administration (before, 16.1 ± 0.1 mm 2 ; after, 16.9 ± 0.3 mm 2 ; n.s.). There were no changes in the spontaneous firing rate after LA administration. Intravenous administration of vehicle had no significant effect on non-noxious and noxious mechanical, and pinch stimulation) activity 
Effects of LA on excitability of SpVc WDR neurons in response to noxious stimuli
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Discussion
Intravenous LA suppresses excitability of SpVc WDR neurons
The aim of the present study was to investigate whether acute intravenous LA administration to rats attenuates the excitability of WDR SpVc neurons in response to nociceptive and non-nociceptive mechanical stimulation in vivo. In the present study, we found that: (i) the mean SpVc WDR neuronal firing rate in response to both non-noxious and noxious mechanical stimuli was significantly and dose-dependently inhibited by LA (1-100 mM i.v.); (ii) the inhibition of the discharge frequency in response to both nonnoxious and noxious mechanical stimuli was reversible and occurred within approximately 10 min; and (iii) injection of vehicle had no significant effect on SpVc WDR neuronal activity in response to either non-noxious or noxious mechanical or pinch stimuli. In a previous study, we showed that the intravenous administration of 100 mM of the dietary supplement theanine suppresses nociceptive SpVc WDR neuronal activity and this effect is maximum 5 min after administration and lasts for 20 min (Takehana et al., 2017) . In the present study, following the systemic administration of 100 mM LA, the drug entered the general circulation and was diluted in the bloodstream to a calculated concentration of approximately 1 mM, and this concentration still had a significant effect on the nociceptive transmission of the SpVc, and took a similar time course of suppression of neural activity as in our previous study (Takehana et al., 2017 channels play an important role in initiating pacemaker activity, such as shaping
subthreshold membrane fluctuation (Nelson et al., 2006; Perez-Reyes, 2003 channels, probably in both primary and secondary neurons. 1t has been demonstrated that T-type Ca 2+ channels are dominantly expressed in the small-(15-30 µm) and medium-diameter (31-40 µm) sensory neurons (Scroggs and Fox, 1992; Schroeder et al., 1990) . These neurons roughly belong to unmyelinated C-and myelinated Aδ-neurons, respectively (Nelson, 2005) . Jevtovic-Todorovic and Todorovic, (2006) found that the amplitude of T-type Ca 2+ currents was increased, causing a reduction in the excitability threshold and consequently an increase in the probability of burst-firing of neurons. Taken together these findings imply that LA inhibits the amplitude of T-type Ca 2+ currents, subsequently causing a reduction in the SpVc WDR neuronal
Suppression of
firing rate in response to noxious mechanical stimuli.
LA has already been described in several reports to suppress or modifies nociceptive neurons via T-type Ca 2+ channels (Lee et al., 2009; François et al., 2014 François et al., , 2015 . Since it has been known that low-threshold T-type Ca 2+ channel (Cav3.2) affects response to nonnoxious range and Cav3.2 expressing selectively at low-threshold mechanoreceptors (François et al.,2015; Wang et al., 2011) , it can be speculated that LA may regulate temporal coding in mechanoreceptors (Wang et al., 2011) and proposed as molecular substrates of allodynia in neuropathic pain (François et al.,2015) . In the present study, we found there was an inhibition of the discharge frequency in response to both non-noxious and noxious mechanical stimuli by LA. The mean magnitude of inhibition by LA of the SpVc WDR neuronal discharge frequency was not significantly greater for noxious compared to non-noxious stimuli in this study. These findings suggest that LA may not to be good agent for the medicinal therapy.
Alternatively, it has been reported that application of LA inhibited T-type Ca (Tang and Aizenman, 1993) . Since the intrathecal administration of NMDA receptor antagonists inhibits nociceptive behavior (Cahusac et al., 1984; Aanosen et al., 1987) it can be assumed that the NMDA receptor signaling system contributes to spinal nociceptive transmission. Thus, it is possible that LA suppresses the glutaminergic excitatory synaptic transmission of SpVc neurons by inhibiting post-synaptic glutamate receptors and presynaptic Ca 2+ channels. However further study is needed to elucidate the mechanism underlying LA effects on the somatosensory system.
Functional significance of LA suppression of nociceptive stimulation-induced excitability of SpVc neurons
Streptozotocin-diabetic rats present with hyperactivity of spinal nociceptive neurons (Morgado and Tavares, 2007) . This increased neuronal activity has been shown to be
associated with a decreased expression of KCC2 in the spinal cord (Jolivalt et al., 2008; Morgado et al., 2008) , which accounts for the shift in the action of γ-aminobutyric acid from "inhibitory" to "excitatory" in the spinal dorsal horn of streptozotocin-treated rats (Jolivalt et al., 2008) . Recently Morgado et al. (2011) reported that LA shows a central effect in diabetic neuropathy by reversing neuronal hyperactivity in the spinal cord, which could be partially mediated by its effects on KCC2 expression and seems to be independent from microglial activity. Since SpVc WDR neurons contribute to the mechanism underlying hyperalgesia and/or referred pain associated with dental pain (Takeda et al., 2000; Nishikawa et al., 2004; Takeda et al., 2005 Takeda et al., , 2012 , in the present study we only investigated the effects of LA on SpVc WDR neuronal activity and did not test nociceptive-specific neurons (Ness and Randich, 2000) . Since graded noxious stimuli applied to the receptive field produce increased firing frequency of SpVc WDR neurons in proportion to stimulus intensity, it can be assumed that WDR neurons play an important role in encoding stimulus intensity from the peripheral tissue to the central nervous system.
Following injury and inflammation of the neural tissue innervating the orofacial area, changes in the properties of these neurons lead to pathological pain, such as hyperalgesia and allodynia (Iwata et al., 1999; Takeda et al., 2012) . In addition, we reported previously that temporomandibular joint inflammation-induced hyperexcitability of SpVc WDR neurons contributes to the ectopic mechanical allodynia innervating the facial skin (Takeda et al., 2005 (Takeda et al., , 2012 . Wei et al. (2013) reported that pre-and post-synaptic switching of γ-aminobutyric acid action associated with KCC2 in the SpVc contributes to trigeminal neuropathic allodynia. It is possible that chronic administration of LA could attenuate trigeminal inflammatory pain. Further study is needed to elucidate this possibility.
Finally, complementary alternative medicine (CAM), including herbal medicines and acupuncture, have been used to treat persistent clinical chronic pain (Rao et al., 1999; Konvicka et al., 2008; Rosenberg et al., 2008) . In addition, studies have investigated the potential effects of diet and dietary supplementation on conditions associated with pain (Shir et al., 2001; Ernest et al., 2003; Tall and Raja, 2004) . Tarumizu et al. (2015) reported that the compound supplement containing LA and theanine (Koshirax) provides some
relief for patients with low back pain, and therefore could be useful as a safe alternative or complement to non-steroidal anti-inflammatory drugs to manage lower back pain.
Interestingly, LA has no known toxic side effects, so the possibility exists that LA may be a candidate CAM, specifically as a therapeutic analgesic agent. Incisions associated with surgery cause acute pain and surgery has been identified as a potential major cause of chronic pain (Perkins and Kehlet, 2000; Kehlet et al., 2006) , thus it is possible that LA could effectively reduce clinical pain, including postoperative pain (Locher-Claus et al., 2005; Tillu et al., 2012) . The results of the present study indicate that acute intravenous LA administration suppresses trigeminal nociceptive transmission in states without inflammatory or neuropathic pain. As such, LA may be a potential therapeutic agent for the treatment of trigeminal nociceptive pain, including clinical pain.
Conclusion
The present study provides evidence that, in the absence of inflammatory or 
